Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26FT5YJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,660
Award facts
- Contract value 100% obligated
- $12,659.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,659.70 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose auto-injector pens on January 28, 2026, with completion expected by January 29, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.999 billion vehicle established through December 31, 2031, which serves as the primary mechanism for supplying comprehensive pharmaceutical products and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc., maintains a substantial portfolio of federal medical procurement contracts, predominantly with the Defense Logistics Agency and its medical supply chain. The company demonstrates consistent capability in fulfilling diverse pharmaceutical requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This particular delivery order for Cosentyx, a biologic immunosuppressant used in the treatment of inflammatory conditions, reflects the company's ongoing role in supporting military and federal healthcare systems with critical pharmaceutical commodities necessary for patient care across the global defense health network.
Quick answers
Who was awarded contract SPE2DR26FT5YJ?
SPE2DR26FT5YJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FT5YJ worth?
The government has obligated $12,660 on SPE2DR26FT5YJ.
Is contract SPE2DR26FT5YJ an order under another contract?
Yes. SPE2DR26FT5YJ is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT5YJ competed?
The extent of competition for SPE2DR26FT5YJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award